Orange Book product · Generic (ANDA)
BACITRACIN ZINC AND POLYMYXIN B SULFATE
BACITRACIN ZINC; POLYMYXIN B SULFATE
At a glance
Jan 26, 1995
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 26, 1995
31 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
BACITRACIN ZINC; POLYMYXIN B SULFATE
Strength
500 UNITS/GM;10,000 UNITS/GM
Dosage form
OINTMENT
Route
OPHTHALMIC
TE code
Not listed
Application
ANDA 064046
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of BACITRACIN ZINC; POLYMYXIN B SULFATE
- 1985POLYSPORINBrand (NDA)
NDA 050167 · GLAXOSMITHKLINE
- 2002BACITRACIN ZINC AND POLYMYXIN B SULFATEGeneric (ANDA)
ANDA 065022 · PADAGIS US
- 1995BACITRACIN ZINC AND POLYMYXIN B SULFATEGeneric (ANDA)
ANDA 064028 · SCIEGEN PHARMS
- 1987BACITRACIN ZINC-POLYMYXIN B SULFATEGeneric (ANDA)
ANDA 062849 · NASKA
- 1983OCUMYCINGeneric (ANDA)
ANDA 062430 · PHARMAFAIR
- —POLYSPORINGeneric (ANDA)
ANDA 061229 · MONARCH PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
